Moss Bio

Moss Bio

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

MOSS Bio is a long-established, private company that operates as a critical supplier to the global diagnostics and life sciences industry. It leverages proprietary liquid stabilization technology and efficient bulk manufacturing processes to produce essential, shelf-stable immunoassay components. The company serves leading manufacturers and distributors worldwide through a collaborative partnership model, supporting customers from assay development through commercial production. Its business is built on reliability, custom service capabilities, and deep expertise in reagent formulation and stabilization.

MicrobiomeBiologics

Technology Platform

Proprietary liquid stabilization technology for immunoassay reagents (substrates, conjugates, buffers), enabling 36+ month shelf-life without lyophilization. Coupled with scalable, ISO-certified bulk manufacturing processes.

Opportunities

The growing global in vitro diagnostics market, especially for point-of-care and decentralized testing, drives demand for stable, ready-to-use reagents.
Opportunities exist in expanding custom development services for novel assays and penetrating emerging geographic markets through distributor networks.

Risk Factors

Key risks include customer concentration on a few large diagnostic manufacturers, potential long-term technological disruption of immunoassays, and competitive pressure from larger life science tools companies.
Supply chain vulnerabilities for raw materials also pose a risk.

Competitive Landscape

MOSS Bio competes with large, diversified life science tools and reagent suppliers (e.g., Thermo Fisher Scientific, Merck KGaA) and other specialized immunoassay reagent manufacturers. Its differentiation is based on deep expertise in liquid stabilization, long product shelf-life, and a partnership-oriented service model for bulk manufacturing.